Sunday, July 20, 2008
pehel.com
Home Latest News Pakistan World Science / Technology Sports Entertainment Health Business
Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R)
Source: Medical News Today E-Mail this News Story to a friend E-Mail this Story
Category: Health
Publication Date: Fri, 09 May 2008 03:00:00 PDT
News URL: http://www.medicalnewstoday.com/articles/106917.php
Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R)Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of central nervous system disorders, including obesity, announced completion of enrollment in NB-303 and NB-304, the final two Phase III clinical trials for Contrave®, its lead obesity product candidate.
Click here for full Story
http://www.medicalnewstoday.com/articles/106917.php
Bookmark this news story online:
Add Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to BlinkListAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to DeliciousAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to DiggAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to FarkAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to FurlAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to BlogarithmAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to MeneameAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to My Yahoo!Add Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to ReddItAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to ShadowsAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to SimpyAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to SpurlAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to Sync2ItAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to MagnoliaAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to NewsVineAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to Ask Jeeves
Add Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to Raw SugarAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to DiigoAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to NetVouzAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to Stumble UponAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to SegnaloAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to Google BookmarksAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to Microsoft LiveAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to BlogMarksAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to WinkAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to TechnoratiAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to Feed Me LinksAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to LinkaGoGoAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to BlueDotAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to Mister WongAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to TailRankAdd Orexigen(R) Therapeutics Announces Completion Of Patient Enrollment In Phase III Clinical Program For Contrave(R) to Yahoo Bookmarks

Comments

No comments found... be the first one to comment on this story :)

Post a Comment
Name:
   
E-Mail Address:
   
Website / Blog URL (optional):
   
Comments:
   
Security Code:
   
  
   By submitting these comments, you are agreeing to our Terms of Service
    
Latest News
Latest News World News Pakistan News Technology News Entertainment News Business News Sports News
bullet Association Between Serum Prostate-Specific Antigen Level, Liver Function Tests And Lipid Profile In Healthy Men
bullet Barriers To The Practice Of Evidence-Based Urology
bullet Impact Of Surgical Volume On The Rate Of Lymph Node Metastases In Patients Undergoing Radical Prostatectomy
bullet Comprehensive Clinic For Gastrointestinal Cancers Opens At Rush University Medical Center, USA
bullet Launch Of Zenith AAA Iliac Legs With Flex Stent Gapping Designed To Have Increased Flexibility And Improved Conformability
bullet Drexel University College Of Nursing Receives $1.4 MM Federal Grant To Spread Nursing Technology Expertise Nationally, USA
bullet A New-Generation Of Simpler Sensors For Detecting Disease-Causing Microbes And Toxins
bullet 'Snow Flea Antifreeze Protein' Could Help Improve Organ Preservation
bullet Killer Kevlar - Clothing That Shields From Germs
bullet The 1st Pan-American Congress On Aesthetic And Anti-Aging Medicine
bullet Michael J. Fox Foundation Awards $2.4 Million For Validation Of Nine Promising Therapeutic Targets For Parkinson's Disease
bullet Medical-Surgical Nurses Can Be Advocates For Family Presence During Resuscitation
bullet Nurses Can Help Patients By Taking A Stand Against Smoking
bullet Study Finds Temperature-Taking Methods Are Not Interchangeable
bullet Treating Depression Reduces Risk Of Heart Disease
bullet Elderly Falls Cut By 11 Percent With Education And Intervention
bullet China Can't Fully Fix Air Quality Problem For Olympics According To URI Researcher
bullet American Public Health Association Applauds New Report On Health Impacts Of Climate Change
bullet Sophie Suffers From A Rare Form Of Mitochondrial Disease That Has Made Her Muscles Extremely Weak, Website Launched
bullet California Academy Of Family Physicians Lauds Congress On Medicare Veto Override; Call On CA Legislators To Similarly Rescind Medi-Cal Cuts
bullet Pharmacy Educators Break Science's Boundaries At 2008 AACP/AFPC Annual Meeting And Seminars
bullet Premera Partners With American Cancer Society To Offer Tobacco Cessation Program - Highest Quit Rate For Employer-Based Programs In The Nation
bullet By 2012, Legitimate Generics Will Account For 20% Of Brazil's Pharmaceuticals And Healthcare Market
bullet ERBITUX® (Cetuximab) Receives Approval In Japan For Use In Advanced Colorectal Cancer
bullet FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion
 
© 2007 Verge Systems